Live Breaking News & Updates on Bioreference Health

Stay updated with breaking news from Bioreference health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

BioReference Health and Prognos Health Collaborate to Advance Precision Medicine and Testing

ELMWOOD PARK, N.J., Nov. 28, 2023 /PRNewswire/ BioReference® Health, LLC (BRH), a leading specialty laboratory in the United States, announced . ....

United States , New Jersey , Elmwood Park , Emily Smith , Prnewswire Bioreference , Anuj Kalsy , Ashley Triscuit , Bioreference Health , Health Inc , Prognos Health , Arrangements At Bioreference Health , Pharmaceutical Arrangements , Sundeep Bhan , Reference Health ,

Opko Health (OPK) Q3 2023 Earnings Call Transcript

OPK earnings call for the period ending September 30, 2023. ....

United Kingdom , United States , Hong Kong , Dipesh Patel , Yale Jen Laidlaw , Maury Raycroft Jefferies , Phillip Frost , Jeffrey Cohen , Ted Tenthoff Piper Sandler , Yale Jen , Elias Zerhouni , Edward Tenthoff , Yi Chen , Charlie Bishop , Maury Raycroft , Jeffrey Cohen Ladenburg Thalmann , Lyvonne Briggs , Charles Bishop , Bioreference Health , Department Of Health , Development Authority , Company Analyst , American Urology Association , Ladenburg Thalmann , Renal Division , Centera Bio ,

BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™

/PRNewswire/ SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced that BioReference®. ....

Elmwood Park , New Jersey , United States , Ellen Beausang , Memorial Sloan Kettering Cancer Center , Health Inc , Bioreference Health , Philippe Menu , Chief Medical Officer , Chief Product Officer , Genpath Oncology , Chief Commercial Officer , Sophia Genetics ,

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

Conference call begins at 4:30 p.m. Eastern time todayMIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nine months ended September 30, 2023. Business highlights from the third quarter and subsequent weeks included the following: ModeX Therapeutics Inc. (ModeX) was awarded a contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop novel multispecific antibodies against vi ....

United Arab Emirates , United Kingdom , United States , Bruce Voss , Lyvonne Briggs , Development Authority , Bioreference Health , Biomedical Advanced Research , Modex Therapeutics Inc , Exchange Commission , Health Inc , Entera Bio Ltd , American Society Of Nephrology Kidney Week , Kidney Week , American Society , Nephrology Kidney , Centera Bio , Reference Health , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements , Opko Health , Gross Profit , Iral Infectious Disease , Clinical Trial , Clinical Data ,

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

MIAMI, Nov. 06, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and nin. ....

United States , United Arab Emirates , United Kingdom , Bruce Voss , Lyvonne Briggs , Health Inc , Exchange Commission , Biomedical Advanced Research , Bioreference Health , Entera Bio Ltd , American Society Of Nephrology Kidney Week , Modex Therapeutics Inc , Development Authority , Kidney Week , American Society , Nephrology Kidney , Centera Bio , Reference Health , Private Securities Litigation Reform Act , Annual Reports , Consolidated Statements ,